Very-Low Risk Myelodysplastic Syndrome

DrugDrug NameDrug Description
DB12281LuspaterceptAn erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms.
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB18646SLN1241Completed1